Tinzaparin in Acute Ischemic Stroke Trial "TAIST"

Completed

Phase 3 Results

Summary of Purpose

To test the safety and efficacy of tinzaparin in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 July 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Leo Pharmaceutical Corp., Ballerup, Denmark

Trial Design

Prospective, international, double-blind, randomized, placebo-controlled trial of 1484 patients.

Contacts

Not available